Bangladesh measles deaths near 900 as coverage drops to 87% post-pandemic

The outbreak began in March 2026 with 92 suspected cases per 100,000 population. Bangladesh's vaccine advisory group launched an emergency measles-rubella campaign in April targeting children 6 months to 5 years, including extra early doses for infants. Vitamin A supplementation and isolation measures were added, supported by WHO, UNICEF, and Gavi. District teams issued weekly reports while hospitals expanded beds, yet pediatric wards filled rapidly with fever and respiratory cases. This response marks the first national campaign since 2020, when political instability and COVID restrictions had already left coverage gaps.

Routine immunization slipped from pre-pandemic targets amid documented hesitancy; nearly half the adult population expressed COVID-vaccine wariness that appears to have transferred to childhood schedules. Observational data link lower maternal education, poverty, and fewer antenatal visits to incomplete measles-rubella uptake. Similar patterns appear in neighboring countries where post-COVID catch-up campaigns lagged, creating contiguous susceptible pockets that allow measles, with its R0 of 12-18, to spread explosively once imported.

Global surveillance shows measles resurgence in at least five countries with coverage below 90% since 2022. Bangladesh's experience underscores that emergency campaigns buy time but cannot replace two-dose routine delivery; without sustained boosters and rumor mitigation, large gatherings risk igniting further waves. Next steps require integrating vitamin A and rapid-response logistics into permanent district plans while monitoring seroprevalence to detect immunity gaps before they widen.